Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation
Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation
Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation
Submitted by
admin
on January 26, 2015 - 9:42am
Source:
Drug Discovery and Development
News Tags:
Aprea
Europe
ovarian cancer
APR-246
Headline:
Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation
Do Not Allow Advertisers to Use My Personal information
